Answers are grounded in this paper and cite their sources.
The L-type amino acid transporter 1 (LAT1), encoded by the SLC7A5 gene, supports cancer-cell growth and nutrient-sensitive signaling. Although LAT1 inhibition has been reported to enhance radiosensitivity in some cancer models, its role in thyroid cancer radiation responses remains unclear. We investigated the association of SLC7A5 with thyroid differentiation and examined whether JPH203 treatment modifies X-ray responses in TPC-1 thyroid cancer cells. SLC7A5 expression, thyroid differentiation score (TDS), and progression-free interval (PFI) were analyzed using The Cancer Genome Atlas thyroid carcinoma dataset. TPC-1 cells were treated with JPH203 and X-ray irradiation. Clonogenic survival and senescence-associated β-galactosidase signal were assessed as longer-term outcomes, whereas cell-cycle distribution, apoptosis, and ribosomal protein S6 (RPS6) phosphorylation were evaluated during the early post-irradiation period. SLC7A5 expression was inversely correlated with TDS but was not significantly associated with PFI in either the overall cohort or the lower-TDS subgroup. JPH203 reduced clonogenic growth in a concentration-dependent manner but did not enhance X-ray-induced loss of clonogenic survival or senescence-associated β-galactosidase signal. In contrast, JPH203 modified early radiation responses, including G2/M accumulation and apoptotic responses. Combined JPH203 and X-ray treatment also altered total and phosphorylated RPS6 signals. JPH203 treatment modifies early cellular responses to X-ray irradiation in TPC-1 cells, but these changes did not translate into enhanced clonogenic radiosensitivity. These findings highlight a temporal dissociation between early radiation-response phenotypes and long-term reproductive cell survival.
No takes yet. Share an insight, caveat, or question.
Kotani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: